Min Shi

10.0k total citations · 3 hit papers
164 papers, 6.7k citations indexed

About

Min Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Min Shi has authored 164 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 41 papers in Oncology and 38 papers in Cancer Research. Recurrent topics in Min Shi's work include Cancer Immunotherapy and Biomarkers (18 papers), Cancer-related molecular mechanisms research (13 papers) and Ferroptosis and cancer prognosis (12 papers). Min Shi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Cancer-related molecular mechanisms research (13 papers) and Ferroptosis and cancer prognosis (12 papers). Min Shi collaborates with scholars based in China, United States and Canada. Min Shi's co-authors include Wangjun Liao, Yulin Liao, Jianping Bin, Rui Zhou, Dongqiang Zeng, Qiong Huang, Wanming He, Shuyi Zhang, Na Huang and Shumin Dong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Min Shi

156 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures

2021 740 citations Dongqiang Zeng, Zilan Ye et al. profile →
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures

2019 697 citations Dongqiang Zeng, Meiyi Li et al. Cancer Immunology Research profile →
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

2017 556 citations Xingbin Hu, Zhaowei Wen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Min Shi China	39	3.5k	2.1k	1.6k	1.6k	882	164	6.7k
Yulin Li China	44	3.3k 0.9×	1.2k 0.6×	704 0.4×	1.1k 0.7×	1.5k 1.7×	220	7.0k
Li Li China	43	3.9k 1.1×	1.7k 0.8×	1.5k 0.9×	1.2k 0.7×	451 0.5×	262	6.3k
Yulin Liao China	56	5.8k 1.7×	2.8k 1.4×	1.9k 1.2×	2.0k 1.2×	1.2k 1.4×	244	11.5k
Min Liu China	43	4.2k 1.2×	2.3k 1.1×	839 0.5×	589 0.4×	544 0.6×	314	7.3k
Mei Wang China	48	5.6k 1.6×	3.4k 1.6×	566 0.3×	922 0.6×	823 0.9×	232	9.3k
Xi Chen China	45	3.7k 1.1×	1.4k 0.7×	802 0.5×	1.4k 0.9×	1.6k 1.8×	347	8.1k
Antonio Domenico Procopio Italy	52	3.5k 1.0×	1.9k 0.9×	1.3k 0.8×	1.3k 0.8×	1.5k 1.7×	181	8.1k
Ling Li China	45	3.7k 1.1×	1.1k 0.5×	515 0.3×	1.1k 0.7×	1.0k 1.2×	304	7.0k
Qiang Xia China	44	3.5k 1.0×	1.6k 0.8×	586 0.4×	769 0.5×	734 0.8×	264	6.4k
Hirotoshi Tanaka Japan	46	4.2k 1.2×	1.9k 0.9×	539 0.3×	1.2k 0.7×	1.0k 1.2×	175	8.0k

Countries citing papers authored by Min Shi

Since Specialization

Citations

This map shows the geographic impact of Min Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Shi more than expected).

Fields of papers citing papers by Min Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Shi. The network helps show where Min Shi may publish in the future.

Co-authorship network of co-authors of Min Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Min Shi. A scholar is included among the top collaborators of Min Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Shi. Min Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Nan, Xinyue Deng, Qiyu Bao, et al.. (2025). Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancer. Autophagy. 21(12). 3004–3023.

Liang, Jian, Xiaomei Li, Xiaobin Li, et al.. (2024). Exploring antithrombotic mechanisms and effective constituents of Lagopsis supina using an integrated strategy based on network pharmacology, molecular docking, metabolomics, and experimental verification in rats. Journal of Ethnopharmacology. 336. 118717–118717. 12 indexed citations

Wang, Fei, et al.. (2023). A comprehensive study of Ephedra sinica Stapf-Schisandra chinensis (Turcz.) Baill herb pair on airway protection in asthma. Journal of Ethnopharmacology. 322. 117614–117614. 4 indexed citations

Hu, Xingbin, Shulong Li, Zhiqi Yao, et al.. (2023). Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer. Cancer Communications. 43(8). 909–937. 61 indexed citations

Xue, Yanan, Wei Yue, Min Shi, et al.. (2023). Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro. Journal of Ethnopharmacology. 318(Pt A). 116933–116933. 13 indexed citations

Zhou, Rui, Nanyan Yang, Zhaowei Wen, et al.. (2023). Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases. Cancer Research. 83(21). 3577–3592. 50 indexed citations

Xu, Xin, et al.. (2023). Design of Efficient and Compact Ultrawideband Rectifier for Sub-6 GHz WPT/EH. IEEE Microwave and Wireless Technology Letters. 33(10). 1490–1493. 15 indexed citations

Pan, Changqie, Jianhua Wu, Siting Zheng, et al.. (2021). Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β ₂ ‐AR/MACC1 axis. Cancer Communications. 41(10). 1049–1070. 38 indexed citations

Zhou, Rui, Yannan Zheng, Zhaowei Wen, et al.. (2021). CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. Oncogene. 40(34). 5342–5355. 23 indexed citations

10.

Zeng, Dongqiang, Jiani Wu, Zilan Ye, et al.. (2021). Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer. Frontiers in Oncology. 11. 620688–620688. 17 indexed citations

11.

Zhou, Rui, Huiying Sun, Siting Zheng, et al.. (2020). A stroma‐related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early‐stage colon cancer. Journal of Cellular and Molecular Medicine. 24(5). 3229–3241. 13 indexed citations

12.

Huang, Qiong, Shao-wei Li, Xingbin Hu, et al.. (2020). Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation. Journal of Experimental & Clinical Cancer Research. 39(1). 25–25. 44 indexed citations

13.

Zeng, Dongqiang, Meiyi Li, Rui Zhou, et al.. (2019). Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunology Research. 7(5). 737–750. 697 indexed citations breakdown →

14.

Zhou, Rui, Dongqiang Zeng, Jingwen Zhang, et al.. (2019). A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer. EBioMedicine. 42. 420–430. 40 indexed citations

15.

Feng, Yanhuan, Fan Guo, Rongshuang Huang, et al.. (2018). SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling. RSC Advances. 8(11). 5891–5896. 6 indexed citations

16.

Shi, Min, Hui Zhang, Ming Liu, et al.. (2018). MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer. Medicine. 97(32). e11505–e11505. 29 indexed citations

17.

Fan, Qi-Wen, et al.. (2018). Effect of leucine on endoplasmic reticulum stress induced by early weaning in the liver of piglets. SHILAP Revista de lepidopterología. 44(2). 172–180. 1 indexed citations

18.

Chi, Honggang, et al.. (2014). Baicalin Improves DSS-Induced Colitis in Mice Via the TLRs/MyD88 Signaling Pathway. Tianran chanwu yanjiu yu kaifa. 26(6). 952. 2 indexed citations

19.

Wang, Lin, Yajun Wu, Lin Li, et al.. (2013). Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. International Journal of Cancer. 133(6). 1419–1430. 98 indexed citations

20.

Shi, Min. (2011). Influence of Buguzhi Decoction on BDNF/TrkB and GAP-43 in the Hippocampus of Vascular Dementia Rats. Journal of traditional chinese medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact